UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry

Lupus, 2020-02, Vol.29 (2), p.176-181

2020

Volltextzugriff (PDF)

Association of IRF5 polymorphism with MPO–ANCA-positive vasculitis in a Japanese population

Genes and immunity, 2013-12, Vol.14 (8), p.527-529

2013

Volltextzugriff (PDF)

THU0463 Complement factors of the alternative pathway in gpa and mpa

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.442

2018

Volltextzugriff (PDF)

SAT0528 Effectiveness of remission-induction therapy with concomitant cyclophosphamide and glucocorticoid for microscopic polyangiitis and granulomatosis with polyangiitis in japan: a propensity score matched analysis of two nationwide prospective cohort studies

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1119

2018

Volltextzugriff (PDF)

Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab

Lupus, 2018-07, Vol.27 (8), p.1374-1377

2018

Volltextzugriff (PDF)

Complement profile in microscopic polyangiitis and granulomatosis with polyangiitis: analysis using sera from a nationwide prospective cohort study

Scandinavian journal of rheumatology, 2020-07, Vol.49 (4), p.301-311

2020

Volltextzugriff (PDF)

AB1322 Treatment response as a predictor for refractory disease and/or transition to rheumatoid arthritis in patients with polymyalgia rheumatica

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1751

2018

Volltextzugriff (PDF)

FRI0233 Classification of 156 japanese patients with anca-associated vasculitides by using the european medicines agency algorism with the addition of surrogate markers for pulmonary vasculitis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.393-393

2013

Volltextzugriff (PDF)

AB0764 The 1st interim analysis of a prospective cohort study of ANCA-associated vasculitides in japan, the remIT-JAV study

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.682-682

2013

Volltextzugriff (PDF)

Acquired haemophilia in a patient with castleman's disease: a case report

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-07, Vol.18 (4), p.e360-e362

2012

Volltextzugriff (PDF)

POS0647 TREATMENT STATUS OF JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS COMPLICATED BY DIABETES MELLITUS: DESCRIPTIVE STUDY USING ADMINISTRATIVE CLAIMS DATABASE

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.780-780

2024

Volltextzugriff (PDF)

POS0455 EFFECT OF ANTI-Ro/SSA ANTIBODIES FOR TREATMENT RESPONSE TO METHOTREXATE IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.458-458

2021

Volltextzugriff (PDF)

AB1633 PREVALENCE TREND OF EGPA AND ANNUAL CHANGES IN ORAL CORTICOSTEROID USE BY PATIENTS WITH EGPA FOLLOWING MEPOLIZUMAB AVAILABILITY IN JAPAN

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.2050-2051

2023

Volltextzugriff (PDF)

THU0315 THE CLINICAL RELEVANCE OF SERUM IMMUNE COMPLEXES IN ANCA-ASSOCIATED VASCULITIS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.386-387

2020

Volltextzugriff (PDF)

AB0547 The prevalence and the risk factor of hypertension and dyslipidemia in systematic lupus erythematosus patients: exploratory research

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.1242

2017

Volltextzugriff (PDF)

FRI0218 PREVALENCE, BURDEN OF DISEASE AND HEALTHCARE UTILIZATION AMONG PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) IN JAPAN 2005-2017

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.692-693

2020

Volltextzugriff (PDF)

POS1104 SERUM C-REACTIVE PROTEIN LEVELS CAN PREDICT ORGAN DAMAGE WITHIN 2 YEARS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO MEET LUPUS LOW DISEASE ACTIVITY STATE

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.945-946

2024

Volltextzugriff (PDF)

POS0737 HIGHER HEALTH-RELATED QUALITY OF LIFE MEASURED BY LUPUS PATIENT-REPORTED OUTCOME WAS ASSOCIATED WITH LOWER INCREASE IN DAMAGE ACCRUAL IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL STUDY USING THE JAPANESE MULTICENTER REGISTRY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.948-949

2024

Volltextzugriff (PDF)

AB1032 INVESTIGATION OF THE INFLUENCE OF SHARED DECISION-MAKING ON THE QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS:THE TRUMP2-SLE STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1836-1837

2024

Volltextzugriff (PDF)

POS1015 SHARED DECISION-MAKING ENHANCES TRUST IN PHYSICIANS IN THE CLINICAL PRACTICE OF SYSTEMIC LUPUS ERYTHEMATOSUS: THE TRUMP2-SLE PROSPECTIVE STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.962-963

2024

Volltextzugriff (PDF)

AB0474 IMPACT OF HEALTH LITERACY ON TRUST IN PHYSICIANS AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE TRUMP2-SLE PROJECT

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1363-1364

2022

Volltextzugriff (PDF)

POS1475-HPR THE MINIMALLY IMPORTANT DIFFERENCE AS THE INTERPRETABILITY OF EMOTIONAL HEALTH DOMAIN IN JAPANESE VERSION OF LupusPRO FOR SLE PATIENTS; PRELIMINARY RESULTS OF A PROSPECTIVE COHORT STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1083-1084

2022

Volltextzugriff (PDF)

POS1404 SHARED DECISION MAKING AND INTERNET USE FOR GATHERING HEALTH INFORMATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER CROSS-SECTIONAL STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1043-1043

2022

Volltextzugriff (PDF)

OP0278-HPR THE RELATIONSHIP BETWEEN HEALTH LITERACY AND TREATMENT STATUS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ACHIEVED LUPUS LOW DISEASE ACTIVITY STATE: THE TRUMP2-SLE PROJECT

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.183-183

2023

Volltextzugriff (PDF)

AB0413 INVESTIGATION OF THE ASSOCIATION OF CARDIOVASCULAR EVENTS AND ANTI- SS-A ANTIBODIES AS RISK OF DEVELOPMENT IN PATIENTS WITH LUPUS NEPHRITIS FROM THE LUNA REGISTRY: A CROSS-SECTIONAL STUDY

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1507-1507

2020

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(35)
Berichte
(1)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

Rheumatology
(14)
Science & Technology
(12)
Systemic Lupus Erythematosus
(10)
Life Sciences & Biomedicine
(9)
Lupus
(9)
Glucocorticoids
(7)
Patients
(7)
Humans
(5)
Immunosuppressive Agents
(5)
Adult
(4)
Female
(4)
Male
(4)
Middle Aged
(4)
Risk Factors
(4)
Antineutrophil Cytoplasmic Antibodies
(3)
Disease
(3)
Drug Dosages
(3)
Granulomatosis
(3)
Hydroxychloroquine
(3)
Prednisolone
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Damage accrual related to pregnancies before and after diagnosis of systemic lupus erythematosus: a cross-sectional and nested case-control analysis from a lupus registry

Association of IRF5 polymorphism with MPO–ANCA-positive vasculitis in a Japanese population

THU0463 Complement factors of the alternative pathway in gpa and mpa

SAT0528 Effectiveness of remission-induction therapy with concomitant cyclophosphamide and glucocorticoid for microscopic polyangiitis and granulomatosis with polyangiitis in japan: a propensity score matched analysis of two nationwide prospective cohort studies

Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab

Complement profile in microscopic polyangiitis and granulomatosis with polyangiitis: analysis using sera from a nationwide prospective cohort study

AB1322 Treatment response as a predictor for refractory disease and/or transition to rheumatoid arthritis in patients with polymyalgia rheumatica

FRI0233 Classification of 156 japanese patients with anca-associated vasculitides by using the european medicines agency algorism with the addition of surrogate markers for pulmonary vasculitis

AB0764 The 1st interim analysis of a prospective cohort study of ANCA-associated vasculitides in japan, the remIT-JAV study

Acquired haemophilia in a patient with castleman's disease: a case report

POS0647 TREATMENT STATUS OF JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS COMPLICATED BY DIABETES MELLITUS: DESCRIPTIVE STUDY USING ADMINISTRATIVE CLAIMS DATABASE

POS0455 EFFECT OF ANTI-Ro/SSA ANTIBODIES FOR TREATMENT RESPONSE TO METHOTREXATE IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

AB1633 PREVALENCE TREND OF EGPA AND ANNUAL CHANGES IN ORAL CORTICOSTEROID USE BY PATIENTS WITH EGPA FOLLOWING MEPOLIZUMAB AVAILABILITY IN JAPAN

THU0315 THE CLINICAL RELEVANCE OF SERUM IMMUNE COMPLEXES IN ANCA-ASSOCIATED VASCULITIS

AB0547 The prevalence and the risk factor of hypertension and dyslipidemia in systematic lupus erythematosus patients: exploratory research

FRI0218 PREVALENCE, BURDEN OF DISEASE AND HEALTHCARE UTILIZATION AMONG PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) IN JAPAN 2005-2017

POS1104 SERUM C-REACTIVE PROTEIN LEVELS CAN PREDICT ORGAN DAMAGE WITHIN 2 YEARS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO MEET LUPUS LOW DISEASE ACTIVITY STATE

POS0737 HIGHER HEALTH-RELATED QUALITY OF LIFE MEASURED BY LUPUS PATIENT-REPORTED OUTCOME WAS ASSOCIATED WITH LOWER INCREASE IN DAMAGE ACCRUAL IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL STUDY USING THE JAPANESE MULTICENTER REGISTRY

AB1032 INVESTIGATION OF THE INFLUENCE OF SHARED DECISION-MAKING ON THE QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS:THE TRUMP2-SLE STUDY

POS1015 SHARED DECISION-MAKING ENHANCES TRUST IN PHYSICIANS IN THE CLINICAL PRACTICE OF SYSTEMIC LUPUS ERYTHEMATOSUS: THE TRUMP2-SLE PROSPECTIVE STUDY

AB0474 IMPACT OF HEALTH LITERACY ON TRUST IN PHYSICIANS AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE TRUMP2-SLE PROJECT

POS1475-HPR THE MINIMALLY IMPORTANT DIFFERENCE AS THE INTERPRETABILITY OF EMOTIONAL HEALTH DOMAIN IN JAPANESE VERSION OF LupusPRO FOR SLE PATIENTS; PRELIMINARY RESULTS OF A PROSPECTIVE COHORT STUDY

POS1404 SHARED DECISION MAKING AND INTERNET USE FOR GATHERING HEALTH INFORMATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER CROSS-SECTIONAL STUDY

OP0278-HPR THE RELATIONSHIP BETWEEN HEALTH LITERACY AND TREATMENT STATUS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO ACHIEVED LUPUS LOW DISEASE ACTIVITY STATE: THE TRUMP2-SLE PROJECT

AB0413 INVESTIGATION OF THE ASSOCIATION OF CARDIOVASCULAR EVENTS AND ANTI- SS-A ANTIBODIES AS RISK OF DEVELOPMENT IN PATIENTS WITH LUPUS NEPHRITIS FROM THE LUNA REGISTRY: A CROSS-SECTIONAL STUDY

Suchergebnisse filtern